John WhiteGloucester VenturesExceptional VenturesKadmos Capital
Description
Big Picture Bio, a newly founded biotech company, has closed a £1.5 million pre-seed funding round co-led by Kadmos Capital and Exceptional Ventures, with participation from Gloucester Ventures and angel investor John White. The company also received £700,000 in non-dilutive funding from Innovate UK, bringing total support to £2.2 million. Big Picture Bio uses generative AI models to identify and optimize cancer combination therapies by understanding interactions between tumors, immune cells, and surrounding tissue. The platform has been validated against real-world clinical outcomes and has demonstrated predictive accuracy on published trials.
Company Information
Company
Big Picture Bio
About
Big Picture Bio Ltd. is an AI-driven oncology company that identifies, designs, and optimizes promising cancer combination therapies using a generative world model to understand tumor, immune cell, and tissue interactions. By combining AI-driven modeling with targeted wet lab validation, the company addresses the challenge of identifying drug combinations with higher likelihood of clinical success. The platform has been validated against real-world clinical outcomes and correctly predicted treatment failures. Big Picture Bio aims to transform cancer drug discovery by treating the disease as a dynamic system rather than targeting single pathways.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Big Picture Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
